advertisement
Abstract #47603 Published in IGR 13-4
Assessment of visual function under treatment with topical antiglaucoma agents and systemic vasodilators. Clinical study on glaucoma patients
Popa SA; Bucatariu PM; Azoicahi D; Costin D; Manole A; Matei M; Merchez MRevista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2011; 115: 455-459
The authors present some observations regarding the use of topical anti-glaucoma therapy and systemic vasodilators. The study was carried out on a series of 996 glaucoma patients, of which 54.1% with primary open-angle glaucoma, 5.7% closed-angle glaucoma, and 17.6% with normal intraocular pressure. Intraocular pressure and visual field were assessed after the use of such therapeutic methods as carbonic anhydrase inhibitors (dorzolamide) and prostaglandin (latanoprost) and dorzolamide (cosopt) association. The favorable progression of glaucoma could be improved by using new etiopathogenic mechanisms and treatment approaches. LA: Romanian
S.A. Popa. Universitatii de Medicina si Farmacie Gr. T. Popa Iasi Universitatea de Medicina si Farmacie Gr. T. Popa Iasi Facultatea de Medicina.
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
11.5.2 Topical (Part of: 11 Medical treatment > 11.5 Carbonic anhydrase inhibitors)
11.13.2 Betablocker and carbon anhydrase inhibitor (Part of: 11 Medical treatment > 11.13 Combination therapy)
11.7 Treatment of bloodflow (Part of: 11 Medical treatment)